NCT01257815View on ClinicalTrials.gov

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Diabetic RetinopathyMacular Oedema
Interventions
DRUG

Ranibizumab

Trial Locations (15)

TQ2 7AA

Novartis Investigative Site, Torquay

HU3 2JZ

Novartis Investigative Site, Hull

KA6 6DX

Novartis Investigative Site, Ayr

BT12 6BA

Novartis Investigative Site, Belfast

B9 5SS

Novartis Investigative Site, Birmingham

CF14 4XW

Novartis Investigative Site, Cardiff

CO3 3NB

Novartis Investigative Site, Colchester

KY12 OSU

Novartis Investigative Site, Fife

NR31 6LA

Novartis Investigative Site, Great Yarmouth

L7 8XP

Novartis Investigative Site, Liverpool

E11 1NR

Novartis Investigative Site, London

SE5 9RS

Novartis Investigative Site, London

CV22 5PX

Novartis Investigative Site, Rugby

UB8 3NN

Novartis Investigative Site, Uxbridge

YO31 8HE

Novartis Investigative Site, York

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY